Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 3,762 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Arm 3 intervention Clear all

Conditions: Opioid-Related Disorders, Buprenorphine, Social Stigma, Rural Health Services
Interventions: Stigma-reduction training, Placebo; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Obesity
Interventions: PATH Intervention, Control Group, Physical activity tracker, Dietary education; Behavioral · Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Patent Ductus Arteriosus, Preterm Infant, Bronchopulmonary Dysplasia
Interventions: Ibuprofen and acetaminophen, Ibuprofen and placebo; Drug
Lead sponsor: University of South Alabama; Other
Eligibility: 5 Days to 21 Days
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Mobile, Alabama

Conditions: Shared Decision-Making, Quality of Life, Advanced Illness, Terminal Illness
Interventions: Research Assistant Support; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Malignant Neoplasm of Large Intestine
Interventions: Care manager outreach; Other
Lead sponsor: Northwestern University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obesity, Pain
Interventions: Use of PDA + support to reduce weight and pain, MOVE! level 2 group weight loss counseling; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Hines, Illinois

Conditions: Functional Impairment, Frailty
Interventions: Screening intervention, Standard bundle of implementation strategies, Enhanced bundle of implementation strategies; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Frailty, Disability or Chronic Disease Leading to Disablement
Interventions: 3-Step Workout for Life; Other
Lead sponsor: University of Florida; Other
Eligibility: 65 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: HIV
Interventions: Aerobic and Strength Training Intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV Infections
Interventions: Text messaging plus EMA, Treatment as usual; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Sleep Disordered Breathing (SDB), Sleep Apnea
Interventions: SSAM, Polysomnography, EnsoSleep; Device · Diagnostic Test
Lead sponsor: Pathway Medtech, LLC.; Industry
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 3
States / cities: Burlingame, California • Irvine, California • La Jolla, California

Conditions: Dementia Severe
Interventions: AMUSED, Reading Aloud; Behavioral
Lead sponsor: Alaine E Hernandez, PhD; Other
Eligibility: 65 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 8
States / cities: Cynthiana, Kentucky • Danville, Kentucky • Lexington, Kentucky + 3 more

Conditions: Adolescent Health Services, Immunization
Interventions: Assessment , Feedback, Incentives, and eXchange Program; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Raleigh, North Carolina

Conditions: Heart Failure, Cardiovascular Disease
Interventions: Kuvan; Drug
Lead sponsor: Providence VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Advance Care Planning Animated Videos
Interventions: Advance care planning animated videos; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years to 89 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Mental Disorders
Interventions: Right Question Project - Mental Health (RQP-MH), Pamphlet; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 724 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 12
States / cities: Boston, Massachusetts • Jamaica Plain, Massachusetts • Malden, Massachusetts + 8 more

Conditions: Help-Seeking Behavior, Pre-exposure Prophylaxis Use, Condomless Sex, Risky Health Behavior
Interventions: Moon and Sun Brothers: A Community Prevention Intervention; Behavioral
Lead sponsor: San Francisco State University; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: San Francisco, California • Chicago, Illinois

Conditions: Vaginal Atrophy, Breast Carcinoma
Interventions: Laser Therapy, Sham Intervention, Questionnaire Administration, Quality of Life Assessment; Device · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 22 Years and older · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Des Moines, Iowa • Ann Arbor, Michigan • Columbus, Ohio

Conditions: Obstructive Sleep Apnea, Nasal Congestion, Sinus Congestion
Interventions: Thermosmart & placebo, Placebo Device & Nasacort, Placebo Arm; Drug · Device
Lead sponsor: Clayton Sleep Insititute; Industry
Eligibility: 16 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Sezary Syndrome
Interventions: Extracorporeal photopheresis (ECP), Methoxsalen Injection; Device · Drug
Lead sponsor: Oleg E. Akilov, MD, PhD; Other
Eligibility: 18 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 3
States / cities: Atlanta, Georgia • Baltimore, Maryland • Pittsburgh, Pennsylvania

Conditions: Barrett Esophagus, Gastroesophageal Reflux Disease, Malignant Digestive System Neoplasm
Interventions: Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy, Linaclotide, Plecanatide; Procedure · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Scottsdale, Arizona • Philadelphia, Pennsylvania • Madison, Wisconsin

Conditions: Cancer
Interventions: Financial navigation, Enhanced usual care; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Metastatic Lung Cancer, Stage IV Lung Cancer
Interventions: Stereotactic Body Radiation Therapy, Pembrolizumab; Radiation · Biological
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sickle Cell Disease
Interventions: Busulfan, Fludarabine, r-ATG, Hematopoietic Cell Transplant, Tacrolimus, Methotrexate, Standard of Care, Alemtuzumab, Total Body Irradiation (TBI), Sirolimus, Melphalan, G-CSF; Drug · Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 15 Years to 40 Years
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 35
States / cities: Oakland, California • Washington D.C., District of Columbia • Gainesville, Florida + 25 more

Search by objective public record fields.

Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing

Active You: Walk, Dance, and Tone Your Abs to Reduce Your Risk of Diabetes

Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus

Empowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care

Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population

PDA+: A Personal Digital Assistant for Obesity Treatment

A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings

Implementing 3-Step Workout for Life in Home Health

Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV

Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users

Detection of Sleep Stages and Arousals Using Neural Network Classifiers

A Multimodal Music Therapy Intervention for Engaging Persons With Severe Dementia

Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina

Rhode Island Diastolic Dysfunction - Heart Failure

A Media Communication Intervention to Increase Engagement in Advance Care Planning Among Cancer Patients

The Right Question Project-Mental Health: An Intervention to Increase Engagement and Retention in Mental Health Care

Moon and Sun Brothers: A Community Prevention Intervention (Hermanos de Luna y Sol)

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure

Extracorporeal Photopheresis in Sezary Syndrome

GCC Agonist Signal in the Small Intestine

Cancer Financial Experience

Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)